stockrowArtiva Biotherapeutics, Inc. (ARTV) vs Protalix BioTherapeutics, Inc. (PLX)
- Artiva Biotherapeutics, Inc. ARTV 4.15 +0.48%
- Protalix BioTherapeutics, Inc. PLX 2.54 +1.20%
Artiva Biotherapeutics, Inc. and Protalix BioTherapeutics, Inc. are both Biotechnology companies. Artiva Biotherapeutics, Inc. and Protalix BioTherapeutics, Inc. are of similar size ($204.7M and $202.9M). Artiva Biotherapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Protalix BioTherapeutics, Inc. trades at 10.6×. Protalix BioTherapeutics, Inc. has the higher net margin (23.5% vs 0.00%) and the higher return on invested capital (48.5% vs 0.00%). Across the 13 metrics below, Protalix BioTherapeutics, Inc. leads on 8 and Artiva Biotherapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ARTV | PLX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 69.20% | 68.51% |
| Operating margin | 0.00% | 28.89% | 0.00% |
| Net margin | 0.00% | 23.50% | 0.00% |
| Free cash flow margin | 0.00% | 9.51% | 0.00% |
| Return on equity | (36.58%) | 31.23% | (51.96%) |
| Return on assets | (33.76%) | 20.07% | (46.06%) |
| Return on invested capital | 0.00% | 48.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack